SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: vestor who wrote (1311)6/11/1999 10:14:00 AM
From: CASINO1  Read Replies (1) | Respond to of 1837
 
The 5% market share for CENESTIN, I think is over conservative. With babyboomers reaching the estrogen supplement need in their age group, there will be a big increase in the use of these drugs. Plus this age group is very aware of their health and drugs they take, which should make CENESTIN the drug of choice, because its made from plants and not from HORSE URINE.